drugset / Trial / NCT01413841

Effect of Oxygen During Percutaneous Coronary Intervention for Pain Relief

NCT01413841

Phase 2 Completed 300 enrolled Region Skane
RandomizedParallel-groupTriple-blindTreatment

Summary

Nasal oxygen is widely used as pain relief against ischemic pain during Percutaneous Coronary Intervention (PCI). However, to our knowledge no randomised clinical trials have tested this. In contrast, oxygen causes coronary artery vasoconstriction in man. Furthermore, a recent Cochrane meta-analysis has shown no evidence of beneficial effect of oxygen for patients with acute myocardial infarction (with normal blood saturation. The investigators therefore wanted to examine if oxygen reduces ischemic pain during PCI for stable angina or NSTEMI.

Timeline

Start
2011-07
Primary completion
2012-06
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxygen Other / unclassified 3 unknown Intranasal